132 related articles for article (PubMed ID: 32235563)
1. The Clinical Impact of Hexanic Extract of
Samarinas M; Karatzas A; Tzortzis V; Gravas S
J Clin Med; 2020 Mar; 9(4):. PubMed ID: 32235563
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of a hexanic extract of Serenoa repens (Permixon
Vela-Navarrete R; Alcaraz A; Rodríguez-Antolín A; Miñana López B; Fernández-Gómez JM; Angulo JC; Castro Díaz D; Romero-Otero J; Brenes FJ; Carballido J; Molero García JM; Fernández-Pro Ledesma A; Cózar Olmos JM; Manasanch Dalmau J; Subirana Cachinero I; Herdman M; Ficarra V
BJU Int; 2018 Dec; 122(6):1049-1065. PubMed ID: 29694707
[TBL] [Abstract][Full Text] [Related]
3. Effects of hexanic extract of Serenoa repens (Permixon® 160 mg) on inflammation biomarkers in the treatment of lower urinary tract symptoms related to benign prostatic hyperplasia.
Latil A; Pétrissans MT; Rouquet J; Robert G; de la Taille A
Prostate; 2015 Dec; 75(16):1857-67. PubMed ID: 26306400
[TBL] [Abstract][Full Text] [Related]
4. The effect of hexanic extract of Serenoa repens on prostatic inflammation: results from a randomized biopsy study.
Gravas S; Samarinas M; Zacharouli K; Karatzas A; Tzortzis V; Koukoulis G; Melekos M
World J Urol; 2019 Mar; 37(3):539-544. PubMed ID: 30027406
[TBL] [Abstract][Full Text] [Related]
5. Clinical Efficacy of Serenoa repens Versus Placebo Versus Alpha-blockers for the Treatment of Lower Urinary Tract Symptoms/Benign Prostatic Enlargement: A Systematic Review and Network Meta-analysis of Randomized Placebo-controlled Clinical Trials.
Russo GI; Scandura C; Di Mauro M; Cacciamani G; Albersen M; Hatzichristodoulou G; Fode M; Capogrosso P; Cimino S; Marcelissen T; Cornu JN; Gacci M; Minervini A; Cocci A;
Eur Urol Focus; 2021 Mar; 7(2):420-431. PubMed ID: 31952967
[TBL] [Abstract][Full Text] [Related]
6. [Alpha-blockers or hexanic extract of Serenoa repens for 6 months: sub-analysis of the PERSAT study].
de la Taille A; Chalret du Rieu Q; Dialla O; Bardin L
Prog Urol; 2023 Feb; 33(2):66-72. PubMed ID: 36207246
[TBL] [Abstract][Full Text] [Related]
7. Clinical Benefit of Tamsulosin and the Hexanic Extract of Serenoa Repens, in Combination or as Monotherapy, in Patients with Moderate/Severe LUTS-BPH: A Subset Analysis of the QUALIPROST Study.
Alcaraz A; Rodríguez-Antolín A; Carballido-Rodríguez J; Castro-Díaz D; Esteban-Fuertes M; Cózar-Olmo JM; Ficarra V; Medina-López R; Fernández-Gómez JM; Angulo JC; Medina-Polo J; Brenes-Bermúdez FJ; Molero-García JM; Fernández-Pro-Ledesma A; Manasanch J; The Qualiprost Study Group OBO
J Clin Med; 2020 Sep; 9(9):. PubMed ID: 32917008
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and Safety of the Hexanic Extract of
Alcaraz A; Gacci M; Ficarra V; Medina-Polo J; Salonia A; Fernández-Gómez JM; Ciudin A; Castro-Díaz D; Rodríguez-Antolín A; Carballido-Rodríguez J; Cózar-Olmo JM; Búcar-Terrades S; Pérez-León N; Brenes-Bermúdez FJ; Molero-García JM; Ledesma AF; Herdman M; Manasanch J; Angulo JC; Group OBOTQS
J Clin Med; 2022 Feb; 11(4):. PubMed ID: 35207238
[TBL] [Abstract][Full Text] [Related]
9. Influence of baseline variables on changes in International Prostate Symptom Score after combined therapy with dutasteride plus tamsulosin or either monotherapy in patients with benign prostatic hyperplasia and lower urinary tract symptoms: 4-year results of the CombAT study.
Roehrborn CG; Barkin J; Tubaro A; Emberton M; Wilson TH; Brotherton BJ; Castro R
BJU Int; 2014 Apr; 113(4):623-35. PubMed ID: 24127818
[TBL] [Abstract][Full Text] [Related]
10. The Role of Combination Therapy with α-Blockers and Hexanic Extract of
De Nunzio C; Salonia A; Gacci M; Ficarra V
J Clin Med; 2022 Dec; 11(23):. PubMed ID: 36498751
[TBL] [Abstract][Full Text] [Related]
11. Quality of life in patients with lower urinary tract symptoms associated with BPH: change over time in real-life practice according to treatment--the QUALIPROST study.
Alcaraz A; Carballido-Rodríguez J; Unda-Urzaiz M; Medina-López R; Ruiz-Cerdá JL; Rodríguez-Rubio F; García-Rojo D; Brenes-Bermúdez FJ; Cózar-Olmo JM; Baena-González V; Manasanch J
Int Urol Nephrol; 2016 May; 48(5):645-56. PubMed ID: 26810324
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and Tolerability of 6-Month Treatment with Tamsulosin Plus the Hexanic Extract of
Alcaraz A; Castro-Díaz D; Gacci M; Salonia A; Ficarra V; Carballido-Rodríguez J; Rodríguez-Antolín A; Medina-Polo J; Fernández-Gómez JM; Cózar-Olmo JM; Búcar-Terrades S; Pérez-León N; Brenes-Bermúdez FJ; Molero-García JM; Fernández-Pro-Ledesma A; Herdman M; Angulo JC; Manasanch J; On Behalf Of The Qualiprost Study Group
J Clin Med; 2022 Jun; 11(13):. PubMed ID: 35806900
[TBL] [Abstract][Full Text] [Related]
13. Serenoa repens + selenium + lycopene vs tadalafil 5 mg for the treatment of lower urinary tract symptoms secondary to benign prostatic obstruction: a Phase IV, non-inferiority, open-label, clinical study (SPRITE study).
Morgia G; Vespasiani G; Pareo RM; Voce S; Madonia M; Carini M; Ingrassia A; Terrone C; Gentile M; Carrino M; Giannantoni A; Blefari F; Arnone S; Santelli G; Russo GI;
BJU Int; 2018 Aug; 122(2):317-325. PubMed ID: 29569389
[TBL] [Abstract][Full Text] [Related]
14. Observational database serenoa repens (DOSSER): overview, analysis and results. A multicentric SIUrO (Italian Society of Oncological Urology) project.
Bertaccini A; Giampaoli M; Cividini R; Gattoni GL; Sanseverino R; Realfonso T; Napodano G; Fandella A; Guidoni E; Prezioso D; Galasso R; Cicalese C; Scattoni V; Armenio A; Conti G; Corinti M; Spasciani R; Liguori G; Lampropoulou N; Martorana G
Arch Ital Urol Androl; 2012 Sep; 84(3):117-22. PubMed ID: 23210402
[TBL] [Abstract][Full Text] [Related]
15. Flower Pollen Extract in Association with Vitamins (Deprox 500®) Versus Serenoa repens in Chronic Prostatitis/Chronic Pelvic Pain Syndrome: A Comparative Analysis of Two Different Treatments.
Macchione N; Bernardini P; Piacentini I; Mangiarotti B; Del Nero A
Antiinflamm Antiallergy Agents Med Chem; 2019; 18(2):151-161. PubMed ID: 30488800
[TBL] [Abstract][Full Text] [Related]
16. Multicentre study on the efficacy and tolerability of an extract of Serenoa repens in patients with chronic benign prostate conditions associated with inflammation.
Giulianelli R; Pecoraro S; Sepe G; Leonardi R; Gentile BC; Albanesi L; Brunori S; Mavilla L; Pisanti F; Giannella R; Morello P; Tuzzolo D; Coscione M; Galasso F; D'Angelo T; Ferravante P; Morelli E; Miragliuolo A;
Arch Ital Urol Androl; 2012 Jun; 84(2):94-8. PubMed ID: 22908779
[TBL] [Abstract][Full Text] [Related]
17. Serenoa repens, lycopene and selenium versus tamsulosin for the treatment of LUTS/BPH. An Italian multicenter double-blinded randomized study between single or combination therapy (PROCOMB trial).
Morgia G; Russo GI; Voce S; Palmieri F; Gentile M; Giannantoni A; Blefari F; Carini M; Minervini A; Ginepri A; Salvia G; Vespasiani G; Santelli G; Cimino S; Allegro R; Collura Z; Fragalà E; Arnone S; Pareo RM
Prostate; 2014 Nov; 74(15):1471-80. PubMed ID: 25154739
[TBL] [Abstract][Full Text] [Related]
18. Clinically Meaningful Improvements in LUTS/BPH Severity in Men Treated with Silodosin Plus Hexanic Extract of Serenoa Repens or Silodosin Alone.
Boeri L; Capogrosso P; Ventimiglia E; Cazzaniga W; Pederzoli F; Moretti D; Dehò F; Montanari E; Montorsi F; Salonia A
Sci Rep; 2017 Nov; 7(1):15179. PubMed ID: 29123161
[TBL] [Abstract][Full Text] [Related]
19. Does the addition of Serenoa repens to tamsulosin improve its therapeutical efficacy in benign prostatic hyperplasia?
Argirović A; Argirović D
Vojnosanit Pregl; 2013 Dec; 70(12):1091-6. PubMed ID: 24450252
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and Safety of Serenoa repens Extract Among Patients with Benign Prostatic Hyperplasia in China: A Multicenter, Randomized, Double-blind, Placebo-controlled Trial.
Ye Z; Huang J; Zhou L; Chen S; Wang Z; Ma L; Wang D; Wang G; Wang S; Liang C; Qiu S; Gu X; Liu J; Weng Z; Wu C; Wei Q; Xie L; Wu W; Cheng Y; Hu J; Wang Z; Zeng X
Urology; 2019 Jul; 129():172-179. PubMed ID: 30880074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
